Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Understanding the effects of ciprofloxacin on corneal epithelial cells: a study using electric cell-substrate impedance sensing (ECIS) technology.

Experimental eye research·2026
Same author

Current Practices in Vestibular Migraine Management Among Canadian Otolaryngologists: A National Survey.

Audiology research·2026
Same author

Beyond impact factor: citation skew and article-level influence in sleep medicine journals.

Sleep & breathing = Schlaf & Atmung·2026
Same author

Sudden hearing loss in enlarged vestibular aqueduct syndrome: a systematic review of treatment and outcomes.

The Journal of laryngology and otology·2026
Same author

Middle Meatal Spacers for Synechiae Prevention Following Endoscopic Sinus Surgery: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Laryngoscope investigative otolaryngology·2026
Same author

Predictors of Fatal Anaphylaxis: A Systematic Review.

International archives of allergy and immunology·2026

Related Experiment Video

Updated: Jun 7, 2026

Electroencephalographic Signal Acquisition Framework for Neurodiverse: A Case Study of Dolphin-Assisted Therapy
07:21

Electroencephalographic Signal Acquisition Framework for Neurodiverse: A Case Study of Dolphin-Assisted Therapy

Published on: June 27, 2025

Adapting and validating the ETDQ-7 for the pediatric population.

Raihanah Alsayegh1, Seokhwan Tommy Kim1, Raisa Chowdhury1

  • 1McGill University Health Centre, Montreal, Quebec, Canada.

International Journal of Pediatric Otorhinolaryngology
|June 5, 2026
PubMed
Summary

The pediatric Eustachian Tube Dysfunction Questionnaire-7 (pETDQ-7) is a reliable tool for assessing quality of life in children with Eustachian Tube Dysfunction (ETD). This validated questionnaire helps quantify the impact of ETD on pediatric patients.

More Related Videos

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
05:48

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients

Published on: June 12, 2020

Measuring the Functional Abilities of Children Aged 3-6 Years Old with Observational Methods and Computer Tools
11:29

Measuring the Functional Abilities of Children Aged 3-6 Years Old with Observational Methods and Computer Tools

Published on: June 20, 2020

Related Experiment Videos

Last Updated: Jun 7, 2026

Electroencephalographic Signal Acquisition Framework for Neurodiverse: A Case Study of Dolphin-Assisted Therapy
07:21

Electroencephalographic Signal Acquisition Framework for Neurodiverse: A Case Study of Dolphin-Assisted Therapy

Published on: June 27, 2025

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
05:48

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients

Published on: June 12, 2020

Measuring the Functional Abilities of Children Aged 3-6 Years Old with Observational Methods and Computer Tools
11:29

Measuring the Functional Abilities of Children Aged 3-6 Years Old with Observational Methods and Computer Tools

Published on: June 20, 2020

Area of Science:

  • Pediatric Otolaryngology
  • Quality of Life Assessment
  • Clinical Validation Studies

Background:

  • Eustachian Tube Dysfunction (ETD) impacts up to 40% of children, affecting development and quality of life.
  • The adult Eustachian Tube Dysfunction Questionnaire-7 (ETDQ-7) lacks validation in pediatric populations.
  • A need exists for a validated tool to assess ETD's impact on children's quality of life.

Purpose of the Study:

  • To adapt and validate the Eustachian Tube Dysfunction Questionnaire-7 (ETDQ-7) for use in pediatric patients.
  • To establish the reliability and validity of the pediatric version (pETDQ-7) as a symptom assessment tool.
  • To quantify the quality of life impact of ETD in children.

Main Methods:

  • An adapted version of the ETDQ-7 (pETDQ-7) was administered to 38 pediatric patients with ETD and 38 controls (aged 4+).
  • Participants completed the pETDQ-7 twice, 4 weeks apart, to assess test-retest reliability.
  • Clinical assessments including otoscopy and tympanometry differentiated ETD from control groups.

Main Results:

  • A statistically significant difference in pETDQ-7 scores was observed between the ETD and control groups (p < 0.0001).
  • An optimal cutoff score of 10 or higher effectively identified patients with ETD (p < 0.0001).
  • The pETDQ-7 demonstrated excellent internal consistency, with a Cronbach's alpha of 0.8622.

Conclusions:

  • The pediatric Eustachian Tube Dysfunction Questionnaire-7 (pETDQ-7) is a reliable and valid instrument for assessing ETD symptom severity.
  • The pETDQ-7 effectively quantifies the quality of life impact of ETD in pediatric patients.
  • This validated tool can aid in monitoring treatment outcomes for pediatric ETD.